BEIJING,Dec. 26,2024-- A report from People\'s Daily: Gonzalo Rios is the deputy general manager of COSCO Shipping Ports Chancay Peru S.A.
01-03
XIAMEN,China,Dec. 27,2024--Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announced that it
01-03
CHICAGO,Dec. 26,2024-- HSG Laser,a global leader in metal shaping equipment and solutions,proudly announces the grand opening of its newest manufacturing facility in Jinan,China—a key milestone in it
01-03
LAS VEGAS and SEOUL,South Korea,Dec. 27,2024--Thinkfree,a global software company in productivity tools and AI technology,will participate in CES 2025,taking place in Las Vegas from January 7 to Janu
01-03
SUZHOU,China,Dec. 27,2024-- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation
01-03
TAIPEI,Dec. 30,2024-- As the calendar turns,ARTERY Technology extends warm New Year greetings! In 2024,leveraging professional expertise and technological breakthroughs,we made steady progress in a ra
01-03
NANTONG and SUZHOU,China,Dec. 31,2024-- Ractigen Therapeutics proudly announces that its Founder and CEO,Dr. Long-Cheng Li,has been honored with the 2024 Life Science Ice Breaking Award. This award,es
01-03
HONG KONG,Jan. 2,2025-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) today announces that Panyu 11-12 Oilfield/Panyu 10-1 Oilfield/Panyu 10-2
01-03
Veteran Technology Executive Joins DXC\'s Leadership Team ASHBURN,Va.,Jan. 3,2025-- DXC Technology (NYSE: DXC),a leading Fortune 500 global technology services provider,today announced the appointment
01-03
TAIPEI,Jan. 2,2025-- MICROIP is redefining IC design by integrating AI software services and pioneering a "Designless" approach,earning recognition from leading global semiconductor compani
01-03
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
